Cokey Nguyen

Company: Atara Biotherapeutics Inc.

Job title: President & Chief Executive Officer

Seminars:

Panel Discussion: Understanding the Merits & Feasibilities of HLA Matching 11:30 am

Explore the importance of HLA matching in improving patient outcomes and reducing the risk of allogeneic rejection in allogeneic therapies Evaluate the feasibility and logistical considerations of implementing HLA matching in clinical settings to optimize donor-recipient compatibility Discuss recent advancements and tools that facilitate HLA matching processes, enhancing the overall efficacy of allogeneic treatmentsRead more

day: Day Two - Track A AM

Industry Leaders’ Fireside Chat: Achieving Allogeneic Product Success by Aligning Innovation with Investor Expectations 8:10 am

An interactive panel discussion from the industry leaders of the field to set the scene on the allogeneic cell therapy space.  Ask your questions live to understand the expert’s thoughts on key topics including: Evaluating key success factors for allogeneic therapies and how they differ from autologous approaches Discussing the role of clinical trial outcomes…Read more

day: Conference Day One

Unleashing the Promise of Cell Therapy for Cancer & Autoimmune Diseases 9:30 am

Highlighting how Atara Bio is innovating next-generation CAR-Ts with the only allogeneic T-cell platform with an approved product  Focusing on how EBV T-cell biology and novel CAR technologies can address the current limitations of autologous and other allogeneic CAR approaches  Describing ATA3219, Atara Bio’s allogeneic CAR-T targeting CD19, for the potential treatment of SLE and NHLRead more

day: Conference Day One